12 Stocks on Jim Cramer’s Radar

Page 11 of 11

1. McKesson Corporation (NYSE:MCK)

Number of Hedge Fund Holdings: 73

McKesson Corporation (NYSE:MCK) is one of the largest healthcare services providers in America. Its shares are up by 59% over the past year and by 15% year-to-date. Several analysts have discussed McKesson Corporation (NYSE:MCK) in 2026. For instance, TD Cowen raised the share price target to $1,012 from $1,000 and kept a Buy rating on the shares in February. The coverage followed McKesson Corporation (NYSE:MCK)’s latest earnings report. TD Cowen commented that the firm’s pharmaceutical and cancer businesses were performing well and added that it had performed well in the earnings despite high expectations. Before the earnings, Morgan Stanley raised the share price target to $966 from $916 and kept an Overweight rating on the shares. McKesson Corporation (NYSE:MCK)’s cancer business also played a role in Morgan Stanley’s optimism. As for Cramer, the CNBC TV host has recently started discussing the firm along with President Trump:

“But do I want to point out the middleman where there’s no rest. The middleman. McKesson today, leading the S&P. This is a company that the President, it’s in his crosshairs, he has failed. They are more powerful than President Trump.”

While we acknowledge the potential of MCK to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than MCK and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

Page 11 of 11